122 related articles for article (PubMed ID: 38564847)
21. Unbiased MRI Analyses Identify Micropathologic Differences Between Upper Motor Neuron-Predominant ALS Phenotypes.
Rajagopalan V; Pioro EP
Front Neurosci; 2019; 13():704. PubMed ID: 31354413
[TBL] [Abstract][Full Text] [Related]
22. Grey matter damage in progressive multiple sclerosis versus amyotrophic lateral sclerosis: a voxel-based morphometry MRI study.
Tavazzi E; Laganà MM; Bergsland N; Tortorella P; Pinardi G; Lunetta C; Corbo M; Rovaris M
Neurol Sci; 2015 Mar; 36(3):371-7. PubMed ID: 25228014
[TBL] [Abstract][Full Text] [Related]
23. Structural explanation of poor prognosis of amyotrophic lateral sclerosis in the non-demented state.
Kim HJ; Oh SI; de Leon M; Wang X; Oh KW; Park JS; Deshpande A; Buj M; Kim SH
Eur J Neurol; 2017 Jan; 24(1):122-129. PubMed ID: 27753163
[TBL] [Abstract][Full Text] [Related]
24. Sensitivity of brain MRI and neurological examination for detection of upper motor neurone degeneration in amyotrophic lateral sclerosis.
Nitert AD; Tan HH; Walhout R; Knijnenburg NL; van Es MA; Veldink JH; Hendrikse J; Westeneng HJ; van den Berg LH
J Neurol Neurosurg Psychiatry; 2022 Jan; 93(1):82-92. PubMed ID: 34663622
[TBL] [Abstract][Full Text] [Related]
25. Voxel-based morphometry study of brain volumetry and diffusivity in amyotrophic lateral sclerosis patients with mild disability.
Agosta F; Pagani E; Rocca MA; Caputo D; Perini M; Salvi F; Prelle A; Filippi M
Hum Brain Mapp; 2007 Dec; 28(12):1430-8. PubMed ID: 17370339
[TBL] [Abstract][Full Text] [Related]
26. Structural imaging differences and longitudinal changes in primary lateral sclerosis and amyotrophic lateral sclerosis.
Kwan JY; Meoded A; Danielian LE; Wu T; Floeter MK
Neuroimage Clin; 2012; 2():151-60. PubMed ID: 24179768
[TBL] [Abstract][Full Text] [Related]
27. Severity of in vivo corticospinal tract degeneration is associated with survival in amyotrophic lateral sclerosis: a longitudinal, multicohort study.
Ta D; Ishaque AH; Elamy A; Anand T; Wu A; Eurich DT; Luk C; Yang YH; Kalra S
Eur J Neurol; 2023 May; 30(5):1220-1231. PubMed ID: 36692202
[TBL] [Abstract][Full Text] [Related]
28. Clinical characteristics associated with corticospinal tract hyperintensity on magnetic resonance imaging in patients with amyotrophic lateral sclerosis.
Kono Y; Sengoku R; Mitsumura H; Bono K; Sakuta K; Yamasaki M; Mochio S; Iguchi Y
Clin Neurol Neurosurg; 2014 Dec; 127():1-4. PubMed ID: 25306412
[TBL] [Abstract][Full Text] [Related]
29. Fiber-specific white matter analysis reflects upper motor neuron impairment in amyotrophic lateral sclerosis.
Ogura A; Kawabata K; Watanabe H; Choy SW; Bagarinao E; Kato T; Imai K; Masuda M; Ohdake R; Hara K; Nakamura R; Atsuta N; Nakamura T; Katsuno M; Sobue G
Eur J Neurol; 2022 Feb; 29(2):432-440. PubMed ID: 34632672
[TBL] [Abstract][Full Text] [Related]
30. [Objective markers for upper motor neuron involvement in amyotrophic lateral sclerosis].
Iwata NK
Brain Nerve; 2007 Oct; 59(10):1053-64. PubMed ID: 17969345
[TBL] [Abstract][Full Text] [Related]
31. Comprehensive evaluation of corticospinal tract metabolites in amyotrophic lateral sclerosis using whole-brain 1H MR spectroscopy.
Govind V; Sharma KR; Maudsley AA; Arheart KL; Saigal G; Sheriff S
PLoS One; 2012; 7(4):e35607. PubMed ID: 22539984
[TBL] [Abstract][Full Text] [Related]
32. Diffusion tensor imaging in amyotrophic lateral sclerosis: volumetric analysis of the corticospinal tract.
Wang S; Poptani H; Bilello M; Wu X; Woo JH; Elman LB; McCluskey LF; Krejza J; Melhem ER
AJNR Am J Neuroradiol; 2006; 27(6):1234-8. PubMed ID: 16775271
[TBL] [Abstract][Full Text] [Related]
33. Longitudinal structural changes in ALS: a three time-point imaging study of white and gray matter degeneration.
Bede P; Hardiman O
Amyotroph Lateral Scler Frontotemporal Degener; 2018 May; 19(3-4):232-241. PubMed ID: 29214883
[TBL] [Abstract][Full Text] [Related]
34. Gray Matter Volume Changes over the Whole Brain in the Bulbar- and Spinal-onset Amyotrophic Lateral Sclerosis: a Voxel-based Morphometry Study.
Chen ZY; Liu MQ; Ma L
Chin Med Sci J; 2018 Mar; 33(1):20-28. PubMed ID: 29620511
[TBL] [Abstract][Full Text] [Related]
35. Comparing brain structural MRI and metabolic FDG-PET changes in patients with ALS-FTD: 'the chicken or the egg?' question.
Rajagopalan V; Pioro EP
J Neurol Neurosurg Psychiatry; 2015 Sep; 86(9):952-8. PubMed ID: 25520437
[TBL] [Abstract][Full Text] [Related]
36. Disparate voxel based morphometry (VBM) results between SPM and FSL softwares in ALS patients with frontotemporal dementia: which VBM results to consider?
Rajagopalan V; Pioro EP
BMC Neurol; 2015 Mar; 15():32. PubMed ID: 25879588
[TBL] [Abstract][Full Text] [Related]
37. Brain white matter diffusion tensor metrics from clinical 1.5T MRI distinguish between ALS phenotypes.
Rajagopalan V; Yue GH; Pioro EP
J Neurol; 2013 Oct; 260(10):2532-40. PubMed ID: 23864396
[TBL] [Abstract][Full Text] [Related]
38. Neurite orientation and dispersion density imaging (NODDI) detects cortical and corticospinal tract degeneration in ALS.
Broad RJ; Gabel MC; Dowell NG; Schwartzman DJ; Seth AK; Zhang H; Alexander DC; Cercignani M; Leigh PN
J Neurol Neurosurg Psychiatry; 2019 Apr; 90(4):404-411. PubMed ID: 30361295
[TBL] [Abstract][Full Text] [Related]
39. Widespread subcortical grey matter degeneration in primary lateral sclerosis: a multimodal imaging study with genetic profiling.
Finegan E; Li Hi Shing S; Chipika RH; Doherty MA; Hengeveld JC; Vajda A; Donaghy C; Pender N; McLaughlin RL; Hardiman O; Bede P
Neuroimage Clin; 2019; 24():102089. PubMed ID: 31795059
[TBL] [Abstract][Full Text] [Related]
40. Brainstem pathology in amyotrophic lateral sclerosis and primary lateral sclerosis: A longitudinal neuroimaging study.
Bede P; Chipika RH; Finegan E; Li Hi Shing S; Doherty MA; Hengeveld JC; Vajda A; Hutchinson S; Donaghy C; McLaughlin RL; Hardiman O
Neuroimage Clin; 2019; 24():102054. PubMed ID: 31711033
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
